At least eight of the top 10 drug makers have paid off their competition to block generics from entering the market, and the FTC estimates that these deals cost consumers and taxpayers $3.5 billion every year in higher drug prices.
The result? Many patients can't get the medicine they need.
Please tell your Senator: End pay for delay.
Sincerely,[Your Name] [Your Address] [City, State ZIP]
If you take action and have not already registered, you will receive periodic updates and communications.
UNITED STATES PUBLIC INTEREST RESEARCH GROUP
44 Winter Street, 4th Fl. • Boston, MA 02108
FEDERAL ADVOCACY OFFICE:
218 D Street SE, 1st Fl. • Washington, DC 20003